TRCT
RENE

Tower Research Capital (TRC)’s Cartesian Growth Corp II RENE Stock Holding History

Tower Research Capital (TRC)’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76
Closed -$872 – 5947
2024
Q3 		$872 Buy
76
+25
+49% +$284 ﹤0.01% 5245
2024
Q2 		$575 Sell
51
-7
-12% -$79 ﹤0.01% 5299
2024
Q1 		$644 Sell
58
-242
-81% -$2.67K ﹤0.01% 5420
2023
Q4 		$3.29K Sell
300
-201
-40% -$2.19K ﹤0.01% 5097
2023
Q3 		$5.43K Buy
+501
New +$5.37K ﹤0.01% 4720
2023
Q2 		– Sell
-99
Closed -$1K – 6312
2023
Q1 		$1K Buy
+99
New +$1.03K ﹤0.01% 5600

Other funds holding RENE

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Tower Research Capital (TRC)'s RENE Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 76 shares — an estimated $872 sold.

Tower Research Capital (TRC) first reported a position in RENE in Q1 2023 and held it in 6 quarters. The position peaked at $5.43K in Q3 2023. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 76 Cartesian Growth Corp II shares in Q4 2024, an estimated $872.
  • Tower Research Capital (TRC) first reported a position in Cartesian Growth Corp II in Q1 2023 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Cartesian Growth Corp II position peaked at $5.43K in Q3 2023.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.